title: Blood collection methods affect cellular protein integrity: implications for clinical trial biomarkers and ZAP-70 in CLL.
authors.affiliation: Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Lisa S
authors.initials: LS
authors.lastname: Chen
authors.affiliation: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Keating
authors.affiliation: Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Varsha
authors.initials: V
authors.lastname: Gandhi
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood* / Q000378:metabolism; D001800:Blood Specimen Collection / Q000295:instrumentation / Q000379:methods*; D002986:Clinical Trials as Topic; D006801:Humans; D015151:Immunoblotting; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood* / Q000378:metabolism; D015203:Reproducibility of Results; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000097:blood* / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D051746:ZAP-70 Protein-Tyrosine Kinase